Product Information
QUETIAPINE ER 300 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.2683 per EA under NDC 16729009612. Its NADAC has been published 466 times since Jun 21, 2017.
The High Outlier badge above means this manufacturer's average price in the QUETIAPINE FUMARATE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729009612
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
5/20/2026
Active Ingredients
QUETIAPINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA090681On Market Since
1/1/2019
Pharmacological Classes
Price Statistics
The NADAC for QUETIAPINE ER 300 MG TABLET has been published 466 times since Jun 21, 2017, and over the history we have for it it has declined 98.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2683 per EA |
|---|---|
| All-time high | $15.5837 (Jul 12, 2017) |
| All-time low | $0.1954 (Nov 20, 2024) |
| 52-week high | $0.2827 |
| 52-week low | $0.2559 |
| Median price | $0.3761 |
| Average price | $0.6576 |
| Largest weekly change | -80.7% (Jul 19, 2017) |
| Weeks tracked | 466 |
| Tracking since | Jun 21, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the QUETIAPINE FUMARATE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of QUETIAPINE ER 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE ER 300 MG TABLET, manufactured by Accord Healthcare Inc., is $0.2683 per EA (NDC 16729009612), effective May 20, 2026.
How has the price of QUETIAPINE ER 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for QUETIAPINE ER 300 MG TABLET has declined 98.3%. It has been tracked across 466 weekly CMS publications since Jun 21, 2017.
What are the highest and lowest recorded NADAC prices for QUETIAPINE ER 300 MG TABLET?
Since Jun 21, 2017, the NADAC for QUETIAPINE ER 300 MG TABLET has ranged from a low of $0.1954 (Nov 20, 2024) to a high of $15.5837 (Jul 12, 2017), with a median of $0.3761 per EA.
Are there cheaper alternatives to QUETIAPINE ER 300 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of QUETIAPINE ER 300 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures QUETIAPINE ER 300 MG TABLET?
QUETIAPINE ER 300 MG TABLET (NDC 16729009612) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification